Pushing the bar in treatment of cervical cancer: what can comprehensive cancer centers do on their own?

Gynecol Oncol. 2013 Nov;131(2):464-6. doi: 10.1016/j.ygyno.2013.08.002. Epub 2013 Aug 9.

Authors

Don S Dizon¹, Allison J Ambrosio, Colleen Feltmate, Alexi A Wright, Susana M Campos, Akila Viswanathan; Cervical Cancer Special Interest Group of Dana Farber/Harvard Comprehensive Cancer Center Gynecologic Cancer Management Team

Collaborators

Cervical Cancer Special Interest Group of Dana Farber/Harvard Comprehensive Cancer Center Gynecologic Cancer Management Team:
Anthony Russell, Marcela delCarmen, Elizabeth DiTavi, Susanne McIlvenna, Rochelle Williams, Meghan D Comeau, Stephen Cannistra, Ursula A Matulonis, Michael J Birrer

Affiliation

¹ Massachusetts General Hospital, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA. Electronic address: ddizon@partners.org.

PMID: 23938373
DOI: 10.1016/j.ygyno.2013.08.002

No abstract available

MeSH terms

Cancer Care Facilities
Clinical Trials as Topic
Female
Humans
Neoplasm Metastasis
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / therapy
Neoplasm Staging
Uterine Cervical Neoplasms / pathology
Uterine Cervical Neoplasms / therapy*